IMCR
Immunocore Holdings plc
Latest close $33.29 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 3 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 1.9M -1.2M | 12.00% 0.00 pts | $30.15 | $28.05 | $33.29 |
| T. Rowe Price Investment Management CIK0001897612 | Feb 28, 2026 observed Mar 6, 2026 filed · 6d Schedule 13G amendment | Reported reduction | 3.0M -2.9M | 12.00% 0.00 pts | $32.30 | $32.94 | $33.29 |
| T. Rowe Price Investment Management CIK0001897612 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Schedule 13G amendment | Earliest Schedule 13G amendment found | 6.0M | 12.00% | $34.71 | $32.38 | $33.29 |